Ionis Pharmaceuticals
IONS
Ionis Pharmaceuticals (IONS) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $115.00 | Aug 31, 2026 |
| BMO Capital | Initiated Coverage | Outperform → Market Perform | $60.00 | Aug 19, 2026 |
| JP Morgan | Maintained | Overweight | $76.00 from $72.00 | Aug 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $115.00 from $125.00 | Jul 30, 2026 |
| Wells Fargo | Maintained | Overweight | $95.00 from $100.00 | Jul 30, 2026 |
| Guggenheim | Maintained | Buy | $89.00 from $106.00 | Jul 21, 2026 |
| Wolfe Research | Downgraded | Outperform → Peer Perform | — | Jul 16, 2026 |
| RBC Capital | Maintained | Outperform | $85.00 from $100.00 | Jul 13, 2026 |
| Citigroup | Maintained | Buy | $100.00 from $115.00 | Jul 10, 2026 |
| Canaccord Genuity | Maintained | Buy | $95.00 from $110.00 | Jul 10, 2026 |
| Barclays | Maintained | Overweight | $90.00 from $115.00 | Jul 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $110.00 from $130.00 | Jul 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $125.00 from $130.00 | Jul 10, 2026 |
| Needham | Maintained | Buy | $86.00 from $105.00 | Jul 9, 2026 |
| Jefferies | Maintained | Buy | $90.00 from $113.00 | Jul 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $130.00 from $125.00 | Jun 25, 2026 |
| Leerink Partners | Maintained | Outperform | $129.00 from $122.00 | Jun 25, 2026 |
| Goldman Sachs | Maintained | Neutral | $75.00 from $74.00 | Jun 25, 2026 |
| Leerink Partners | Maintained | Outperform | $122.00 from $114.00 | Jun 17, 2026 |
| TD Cowen | Maintained | Buy | $108.00 | Jun 15, 2026 |
Frequently asked questions
What is the latest analyst rating on IONS?
On Aug 31, 2026, HC Wainwright & Co. maintained Ionis Pharmaceuticals at Buy with a price target of $115.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.